A study conducted by researchers at Hasbro Children’s Hospital, Boston Children’s Hospital, Fairfax (VA) County Public Schools and the University of Colorado School of Medicine has found that…
Tracking retinal changes may help doctors to adjust schizophrenia treatment in the future
Schizophrenia is associated with structural and functional alterations of the visual system, including specific structural changes in the eye. Tracking such changes may provide new measures of risk for, and progression of the disease, according to a li…
Uncategorized
Ocular Therapeutix reports net loss of $10 million in second quarter
Ocular Therapeutix reported a net loss of $10 million, or $0.45 per share, in the second quarter compared with a net loss of $6.4 million, or $2.10 per share, in the same quarter of 2014, according to a press release. Operating expenses increased to $1…
Uncategorized
InSite Vision Announces FDA Acceptance of NDA Filing for BromSite™ (0.075% bromfenac)
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Announces FDA Acceptance of NDA Filing for BromSite™ (0.075% bromfenac)
Research and Markets: Dry (Atrophic) Macular Degeneration Pipeline Insights 2015 – Reviews Key Players Involved in the Therapeutics Development for Dry (Atrophic) Macular Degeneration
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/t595n6/dry_atrophic) has announced the addition of the “Dry (Atrophic) Macular Degeneration-Pipeline Insights” report to their offering. Summary Dry (Atrophic) Ma…
Uncategorized
Research and Markets: Corneal Graft Rejection Pipeline Insights 2015 – Reviews Key Players Involved in the Therapeutics Development for Corneal Graft Rejection
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/5qdg4q/corneal_graft) has announced the addition of the “Corneal Graft Rejection-Pipeline Insights” report to their offering. Summary Corneal Graft Rejection- Pip…